New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Ingevity Corporation
NGVT
Shape
US Flag

NYSE

2B

Chemicals - Specialty

Next Earning date - 19 Feb 2025

2B

Chemicals - Specialty

Next Earning date - 19 Feb 2025

48.57USD
Shape0.84 ( 1.76%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-64%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

14%

Quote Panel

Shape
Updated December 2, 2024
1W 2.23 % 1M 15.86 % 3M 27.45 % 1Y 20.88 %

Key Metrics

Shape
  • Market Cap

    1.77B


  • Shares Outstanding

    36.35M


  • Share in Float

    35.99M


  • Dividende

    0


  • Earning Date

    19 Feb 2025


  • Price Target

    48.57


  • Average Volume

    343965


  • Beta

    1.607


  • Range

    30.9-56.3


  • Industry

    Chemicals - Specialty


  • Website

    https://www.ingevity.com


  • Sector

    Basic Materials


Fundamentals

Shape

17.10x

P/E Ratio

1.19x

P/S Ratio

8.22x

P/B Ratio

7.1

Debt/Equity

-38.1%

Net Margin

$-15.5

EPS

How NGVT compares to sector?

P/E Ratio

Relative Strength

Shape

NGVT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape285%

2025-Revenue

$4.05

Shape237%

2025-EPS

$376M

Shape531%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

CJS Securities

upgrade

Previous: Not converted

2024-08-07

Now: Outperform

BMO Capital

downgrade

Previous: Not converted

2023-08-07

Now: Perform

Loop Capital Markets

upgrade

Previous: Not converted

2023-07-27

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-44%

0.41
vs 0.74

Q1.23

arrow
arrow

-33%

1.09
vs 1.62

Q2.23

arrow
arrow

-18%

1.41
vs 1.73

Q3.23

arrow
arrow

-42%

1.21
vs 2.09

Q4.23

arrow
arrow

-49%

0.21
vs 0.41

Q1.24

arrow
arrow

-52%

0.52
vs 1.09

Q2.24

arrow
arrow

-28%

1.01
vs 1.41

Q3.24

arrow
arrow

-9%

1.1
vs 1.21

Q4.24

arrow
arrow

+20%

0.25
vs 0.21

Q1.25

arrow
arrow

+39%

0.72
vs 0.52

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+14%

383.6M  vs 336M

Q1.23

arrow
arrow

+3%

392.6M  vs 382.8M

Q2.23

arrow
arrow

+15%

481.8M  vs 419.9M

Q3.23

arrow
arrow

-7%

446M  vs 482M

Q4.23

arrow
arrow

-3%

371.7M  vs 383.6M

Q1.24

arrow
arrow

-13%

340.1M  vs 392.6M

Q2.24

arrow
arrow

-19%

390.6M  vs 481.8M

Q3.24

arrow
arrow

-15%

376.9M  vs 446M

Q4.24

arrow
arrow

-16%

310.8M  vs 371.7M

Q1.25

arrow
arrow

-6%

320.8M  vs 340.1M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+2%

0.02
vs 0.12

Q1.23

arrow
arrow

+7%

0.07
vs 0.02

Q2.23

arrow
arrow

+5%

0.05
vs 0.07

Q3.23

arrow
arrow

+4%

0.04
vs 0.05

Q4.23

arrow
arrow

-18%

-0.18
vs 0.04

Q1.24

arrow
arrow

-10%

-0.10
vs -0.18

Q2.24

arrow
arrow

-100%

-1.00
vs -0.10

Q3.24

arrow
arrow

-50%

-0.50
vs -1.00

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

290

290
vs 264

10%

Q1.23

arrow
arrow

282

282
vs 290

-3%

Q2.23

arrow
arrow

255

255
vs 282

-10%

Q3.23

arrow
arrow

262

262
vs 255

3%

Q4.23

arrow
arrow

253

253
vs 262

-3%

Q1.24

arrow
arrow

261

261
vs 253

3%

Q2.24

arrow
arrow

265

265
vs 261

2%

Q3.24

arrow
arrow

258

258
vs 265

-3%

Earnings Growth

Latest News